Kegg medicus dgroup en
| DG01493 | |
| DG number | DG01493 |
| Classification | DGroup |
| Name | GLP-1 receptor agonist Glucagon-like peptide 1 receptor agonist |
| Stem | -glutide, -natide, -glipron TYPE Target, Class |
| Structural formula |  |
| Member | D04121 Exenatide (JAN/USAN/INN) D06404 Liraglutide (USAN/INN); Liraglutide (genetical recombination) (JAN) D09729 Lixisenatide (JAN/USAN/INN) D08843 Albiglutide (USAN); Albiglutide (genetical recombination) (JAN) D09889 Dulaglutide (USAN/INN); Dulaglutide (genetical recombination) (JAN) D10025 Semaglutide (USAN/INN); Semaglutide (genetical recombination) (JAN) D11924 Beinaglutide (INN) D11360 Tirzepatide (JAN/USAN) D09723 Taspoglutide (USAN/INN) D10970 Pegapamodutide (USAN/INN) D12225 Mazdutide (USAN) D12341 Vurolenatide (USAN/INN) DG03125 Danuglipron D11910 Danuglipron (USAN) D11911 Danuglipron tromethamine (USAN) DG03257 Orforglipron D12536 Orforglipron (USAN) D12529 Orforglipron calcium (USAN) D12555 Lotiglipron (USAN) |
| Upper group | Antidiabetic agent DG02044 Hypoglycemic agent |
| Remark | ATC code: A10BJ |
| Comment | - |